Initially they focused on laboratory aspects of drug concentration measurement then they changed more to the application of TDM in a clinical setting” Reeves et al (2016).
Abstract:
Since the Journal of Antimicrobial Chemotherapy was first published in 1975, papers addressing therapeutic drug monitoring (TDM) have been a regular feature. Initially they focused on laboratory aspects of drug concentration measurement then they changed more to the application of TDM in a clinical setting.
[ctt link=”YdCiF” template=”1″]ReTweet if useful… Forty year review of therapeutic drug monitoring http://ctt.ec/YdCiF+ @ivteam #ivteam[/ctt]
Over its history, the Journal has provided its readership with the latest technological and scientific advances in TDM and has helped to drive changes in TDM that have directly impacted on patient care. These have varied from improvement in the quality of antimicrobial measurements through better identification of dosage regimens and TDM targets that help predict outcome and adverse events. Despite these advances in our understanding of the science and practice of TDM, there remain many areas of uncertainty. As we move into the next 40 years, it is clear that the Journal will continue to provide the readership with the latest science and opinion in this important area.
Reference:
Reeves, D., Lovering, A. and Thomson, A. (2016)
Therapeutic drug monitoring in the past 40 years of the Journal of Antimicrobial Chemotherapy. 71(12), p.3330-3332.
doi: 10.1093/jac/dkw408
Thank you to our partners for supporting IVTEAM
[slideshow_deploy id=’23788’]